PMI Q1 Revenue Hits $9.3B, ZYN US Shipments Jump 53% to 200M Cans

Apr.24.2025
PMI Q1 Revenue Hits $9.3B, ZYN US Shipments Jump 53% to 200M Cans
In Q1 2025, Philip Morris International reported net revenue of $9.301 billion, up 5.8% year-over-year, with operating income rising 16.4% to $3.544 billion. Smoke-free products accounted for 42% of net revenue and 44% of gross profit. Total shipment volume grew 14.4%, with heated tobacco products like IQOS reaching record market shares in Japan and Europe. ZYN nicotine pouch shipments in the U.S. surged 53% year-over-year.

Key Points:

Net income reached $9.301 billion, a year-on-year increase of 5.8%; organic growth reached 10.2%, mainly benefiting from the growth in sales of smoke-free products and price optimization.

Operating profit increased by 16.4% to $3.544 billion, with adjusted profit reaching $3.79 billion and profit margin rising to 40.7%.

Smoke-free products have made a significant contribution, accounting for 42% of total net revenue and 44% of total gross profit. Shipments have increased by 14.4%, with organic growth in gross profit reaching as high as 33.1%.

IQOS continues to expand its market presence, with market share increasing to 32.2% in Japan and 11.4% in Europe. Global shipments of Heat-Not-Burn Tobacco Units (HTU) also grew by 11.9%.

ZYN Nicotine Pouches Shipments Increase by 53%: ZYN shipments in the United States exceed 200 million cans, surpassing expectations, thanks to early capacity improvements and strong demand.


 

On April 23, 2025, Philip Morris International (PMI) released its first quarter financial results for 2025 on its official website. The report showed that net revenue for the first quarter reached $9.301 billion, with a growth rate of 5.8%. Operating profit was $3.544 billion, an increase of 16.4%. Due to the significant growth in Q1, Philip Morris International (PMI) has raised its full-year earnings forecast for 2025.

 

Net income increased by 5.8% to $9.301 billion, while operating profit grew by 16.4% to $3.544 billion

 

·Earnings Per Share (EPS): Diluted earnings per share reported increased by 24.6% to $1.72. Adjusted diluted earnings per share were $1.69, a growth of 12.7%; excluding the impact of exchange rates, the growth rate reached 17.3%.

 

·Net income: Net income reached $9.301 billion, with a reported growth rate of 5.8% and organic growth rate of 10.2%. The growth was primarily driven by favorable pricing factors and a strong sales/product mix, especially an increase in sales of non-smoking products.

 

·Operating profit: The reported operating profit was $3.544 billion, an increase of 16.4%. The adjusted operating profit was $3.79 billion, with an organic growth rate of 16.0%. The adjusted operating profit margin increased from 38.2% in the same period last year to 40.7%.

 

PMI Q1 Revenue Hits $9.3B, ZYN US Shipments Jump 53% to 200M Cans
2025 first quarter financial report | Source: PMI

 

The smoke-free business contributed 42% of the net income, while the revenue from traditional cigarette business remained stable

 

The smoke-free business continues to serve as a growth engine, contributing 42% of the company's net revenue and 44% of total gross profit.

 

Sales of smoke-free products increased by 14.4%. Net revenue reported a growth of 15.0% (organic growth of 20.4%), while gross profit reported a growth of 27.7% (organic growth of 33.1%).

 

Heated Tobacco Products (HTU): IQOS continues to strengthen its market position, increasing its market share in the combined market of cigarettes and heated tobacco devices by 1.0 percentage points, surpassing 9%. The global shipment volume of HTU (pod units) grew by 11.9% to 37.1 billion units.

 

·In Japan, IQOS's adjusted market share increased by 3.0 percentage points to reach a record high of 32.2%. 

·In Europe, IQOS HTU's adjusted market share increased by 1.2 percentage points to reach a record high of 11.4%.

 

The shipment volume of e-cigarette (E-vapor) products such as VEEV has more than doubled, driven primarily by the European market, leading to a further expansion of profit margin.

 

Oral SFP (Oral Smoke-Free Products): Shipments (measured in pouches or equivalent units) increased by 27.2%, reaching 5.3 billion units. In the United States, ZYN nicotine pouch shipments increased by 53%, surpassing 200 million cans, exceeding expectations, thanks to early capacity increases and strong demand.

 

The volume of cigarette shipments increased slightly by 1.1%, reaching 144.8 billion units. Net revenue from cigarette business remained stable (organically increasing by 3.8%), while gross profit realized a 2.0% growth (organically increasing by 5.3%). The global brand portfolio, especially Marlboro, drove overall market share in the cigarette category up by 0.4 percentage points to 24.8%.

 

Outlook for the year 2025

 

·PMI has raised its full-year adjusted diluted earnings per share forecast (excluding currency effects). 

·The diluted earnings per share for the report are expected to range from $7.01 to $7.14. 

·Adjusted diluted earnings per share are expected to range from $7.36 to $7.49, representing an increase of 12.0% to 14.0% from $6.57 in 2024. After excluding the favorable currency impact of $0.10, the expected growth is 10.5% to 12.5%.

 

The CEO of the company, Jacek Olczak, stated, "Despite the uncertain and volatile global economic environment, we remain confident in our ability to achieve outstanding performance and predict double-digit growth in adjusted diluted earnings per share for the full year in US dollars."

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Product | BAT Expands VELO Peach Ice Medium to FamilyMart Stores Nationwide in Japan
Product | BAT Expands VELO Peach Ice Medium to FamilyMart Stores Nationwide in Japan
British American Tobacco Japan (BAT Japan) expanded VELO Peach Ice Medium to FamilyMart stores nationwide in Japan from September 7, 2026. The oral tobacco product first launched on July 6 and had previously been sold through VELO's official online store, glo Store Ginza and tobacco retailers. It combines peach flavor with menthol cooling at a Medium strength level and is priced at JPY 360. Japanese tobacco retailers list 15 pouches per pack. The move adds the new SKU to an existing nationwide FamilyMart distribution network for VELO rather than marking the brand's first entry into the convenience-store chain.
Sep.15
2Firsts Compliance Solutions Hosts PMTA Briefing on FDA Review Signals After JUUL2 Authorization
2Firsts Compliance Solutions Hosts PMTA Briefing on FDA Review Signals After JUUL2 Authorization
Following recent FDA authorizations for JUUL2 and ZYN ULTRA, 2Firsts Compliance Solutions held an online PMTA briefing on Sept. 4 to examine what the decisions may signal about review efficiency, scientific evidence and U.S. market access. Nearly 30 participants from brands, manufacturers, compliance service providers and investment firms joined the discussion.
2Firsts Events
Sep.06
From Vuse, Velo and glo to AI Consulting: Former BAT Content Lead Launches Destreza
From Vuse, Velo and glo to AI Consulting: Former BAT Content Lead Launches Destreza
Former BAT global content lead Andy Parton has left the company and launched Destreza, a London-based AI-native marketing consultancy. Parton previously worked across BAT's New Category brands Vuse, Velo and glo and had also served as Global Brand Lead for Vuse Go. Destreza says it will advise consumer businesses on AI in brand strategy, operating models, capability and agency configuration, using specialist AI agents to support research, strategy and creative development. BAT reported £3.621 billion in New Category revenue in 2025.
Sep.22
Arizona Turns to a 50% Retail Vape Tax as Tobacco Tax Revenue Falls 47% From 2008
Arizona Turns to a 50% Retail Vape Tax as Tobacco Tax Revenue Falls 47% From 2008
Arizona's First Things First is pushing for an excise tax equal to 50% of the retail price of vaping products, estimating that the measure could generate about $100 million annually. The agency says its tobacco-tax revenue has fallen 47% from 2008 levels. Arizona has attempted to broaden its nicotine tax base in each of the past two years: a 2025 bill proposed a 50% wholesale-price tax, while a 2026 measure shifted to a 50% retail-price tax covering alternative nicotine products and vapor products. Separately, the state enacted HB 4001 this year to establish a new licensing and sales framework for alternative nicotine products.
Sep.21
Special Report | Altria Subsidiaries Sue FDA to Vacate 2021 PMTA Rule as Agency Moves to Speed Reviews
Special Report | Altria Subsidiaries Sue FDA to Vacate 2021 PMTA Rule as Agency Moves to Speed Reviews
2Firsts reviewed the original federal court complaint filed by Altria subsidiaries Helix Innovations and NJOY on Sept. 2 challenging FDA’s 2021 PMTA rule. The lawsuit questions whether FDA’s review process complies with the Tobacco Control Act’s 180-day timeline, even as the agency moves to accelerate PMTA reviews and issues more marketing orders. Drawing on the complaint, FDA records, government audits and recent court rulings, 2Firsts examines the legal arguments, supporting evidence and potential implications for the U.S. tobacco review system.
Regulations
Sep.03
PMI Expands Colorado Investment to $1.2 Billion to Boost ZYN Nicotine Pouch Production
PMI Expands Colorado Investment to $1.2 Billion to Boost ZYN Nicotine Pouch Production
Philip Morris International (PMI) is expanding its investment in its Golden, Colorado campus, bringing total investment to approximately $1.2 billion to support its smoke-free products business. The investment will strengthen PMI’s research, production and innovation capabilities in smoke-free products. As one of the world’s largest tobacco companies, PMI has continued advancing its “Smoke-Free Future” strategy through heated tobacco, oral nicotine and other reduced-risk product categories.
PMI
Jul.28